Xanthopterin

Xanthopterin

SCHEMBL906221

Nc1nc(=O)c2[nH]c(=O)cnc2[nH]1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ THRB P10828 1/20 0.54
▸ LMNA P02545 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ USP2 O75604 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ MAPK3 P27361 1/20 0.40
▸ XDH P47989 1/20 0.40
▸ HBB P68871 1/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xanthopterin SCHEMBL2489021 0.98 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL16247077 0.82 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTHSD17B10HPGD
Guanine SCHEMBL342789 0.76 ADORA3 (0.62) ALDH1A1HPGDUSP2TP53ADORA3
Guanine SCHEMBL28026510 0.73 ADORA3 (0.59) ALDH1A1HPGDUSP2TP53ADORA3
Xanthopterin SCHEMBL906219 0.70 KDM4E (1.00) ALDH1A1KDM4EMAPTHSD17B10HPGD
Isoxanthopterin SCHEMBL1331103 0.70 KDM4E (0.54) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL1366331 0.69 MAPT (0.37) ALDH1A1KDM4EMAPTHSD17B10HPGD
Xanthopterin SCHEMBL6475881 0.69 KDM4E (0.96) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL1981722 0.68 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL22497884 0.68 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473287-B2 Synthetic co-crystals of anhydrous guanine and process for preparing the same ECOCRYSTAL LTD. (IL) 2025-11-18 — — US claimed
US-20240208977-A1 SYNTHETIC CO-CRYSTALS OF ANHYDROUS GUANINE AND PROCESS FOR PREPARING THE SAME ECOCRYSTAL LTD. (IL) 2024-06-27 — — US claimed
US-11858936-B2 Synthetic co-crystals of anhydrous guanine and process for preparing the same GUR, Dvir (IL) 2024-01-02 — — US claimed
US-11415583-B2 Method, kit, and apparatus for cancer detection using urinary tumor markers NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2022-08-16 — — US claimed
US-20220098199-A1 SYNTHETIC CO-CRYSTALS OF ANHYDROUS GUANINE AND PROCESS FOR PREPARING THE SAME GUR, Dvir (IL) 2022-03-31 — — US claimed
US-20200150124-A1 METHOD, KIT, AND APPARATUS FOR CANCER DETECTION USING URINARY TUMOR MARKERS NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY 2020-05-14 — — US claimed
EP-3650862-A2 METHOD, KIT, AND APPARATUS FOR CANCER DETECTION USING URINARY TUMOR MARKERS National University Corporation Nagoya University (JP) 2020-05-13 — — EP claimed
CN-110787158-A Application of D609 in preparing medicine for preventing and treating retina injury diseases 中山大学中山眼科中心 2020-02-14 — — CN claimed
US-20190293653-A1 URINE METABOLITE MARKER FOR CHILDHOOD CANCER HITACHI, LTD. (JP) 2019-09-26 — — US claimed
WO-2019175332-A1 BH4 PATHWAY INHIBITION AND USE THEREOF FOR TREATING T-CELL MEDIATED AUTOIMMUNE DISEASES OR HYPERSENSITIVITY IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) 2019-09-19 — — WO claimed
EP-1121111-A2 COMPOUNDS FOR THE TREATMENT OF WEIGHT LOSS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2001-08-08 — — EP claimed
EP-0673783-B1 Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds XEROX CORP (US) 2000-07-05 — — EP claimed
WO-2000023448-A1 NOVEL PTERIN ANTINEOPLASTIC AGENTS MOHENO PHILLIP B B (US) 2000-04-27 — — WO claimed
WO-2000021509-A2 METHODS OF TREATMENT IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2000-04-20 — — WO claimed
US-5659348-A APPLYING TO A SUBSTRATE XEROX CORPORATION (US) 1997-08-19 — — US claimed
US-5534514-A ANTITUMOR AGENTS OR FOR TREATMENT OF LEUKEMIA USING MIXTURES OF XANTHOPTERIN AND ISOXANTHOPTERIN SUSPENSION OF CARRIER SAN DIEGO STATE UNIVERSITY (US) 1996-07-09 — — US claimed
EP-0673783-A2 Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds XEROX CORPORATION (US) 1995-09-27 — — EP claimed
EP-0170414-B1 PROCESS FOR TREATING METAL SURFACE Hitachi Chemical Co., Ltd. (JP) 1991-04-17 — — EP claimed
US-4643793-A WITH MIXTURE OF COPPER COMPOUND, COMPLEXING AGENT, REDUCING AGENT, AND PH ADJUSTER IN PRESENCE OF NITROGEN HETEROCYCLE COMPOUND HITACHI CHEMICAL COMPANY, LTD. (JP) 1987-02-17 — — US claimed
EP-0170414-A2 Process for treating metal surface Hitachi Chemical Co., Ltd. (JP) 1986-02-05 — — EP claimed
Send feedback